Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma

Therapeutic options for treating advanced melanoma have progressed rapidly in recent decades. Until 6 years ago, the regimen for treating advanced melanoma consisted mainly of cytotoxic agents such as dacarbazine and type I interferons. Since 2014, anti-programmed cell death 1 (PD1) antibodies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Taku, Muto, Yusuke, Asano, Yoshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779655/
https://www.ncbi.nlm.nih.gov/pubmed/36555362
http://dx.doi.org/10.3390/ijms232415720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779655/
https://www.ncbi.nlm.nih.gov/pubmed/36555362
http://dx.doi.org/10.3390/ijms232415720

Ejemplares similares